Skip to content

Veteran Peer-Assisted Computerized Cognitive Behavioral Therapy for Depression

Veteran Peer-Assisted Computerized Cognitive Behavioral Therapy for Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02057042
Enrollment
330
Registered
2014-02-06
Start date
2015-06-01
Completion date
2018-09-30
Last updated
2019-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Peer Support, cCBT, primary care

Brief summary

The investigators will conduct a randomized clinical trial of Peer-Supported cCBT versus enhanced usual care (EUC) for 330 patients with new episodes of depression in primary care at three VA sites and their associated Community-Based Outpatient Clinics (CBOCs).

Detailed description

Background: Antidepressant medications and evidence-based psychotherapies are effective treatments for depression. However, antidepressant medication adherence continues to be suboptimal and offering access to and retaining patients in evidence-based psychotherapies for depression is challenging. The VHA has made major efforts to expand access to and capacity for depression focused evidence-based psychotherapies. However in 2012, only 35% of VA patients with depression completed any psychotherapy visit and only 6% completed 8 psychotherapy visits in 14 weeks, a proxy for an adequate trial. Initiation and engagement in depression treatment may be increased if patients are offered timely access to a highly flexible, evidence-based treatment options, such as a tailored, web-based computerized cognitive-behavioral therapy (cCBT) program. cCBT has sufficient evidence for effectiveness to be a covered benefit in United Kingdom National Health Service, but has much larger effects when it is supported by clinicians or other trusted individuals. VA peer specialists, an increasing workforce in VHA mental health, are ideal candidates to support patients' engagement in depression treatment and in cCBT. Peers have been shown to promote use of Internet self-management tools, and peer specialist support for cCBT may enhance its completion and overall effectiveness through regular check ins and also through providing peer specific experiences, such as sharing of lived experiences and modeling of self management and recovery. Objectives: We are conducting a Hybrid Type I RCT of Peer-Supported cCBT versus enhanced usual care (EUC) for 330 patients with new episodes of depression in primary care at three VA sites and their associated CBOCs. Our specific aims are to compare PS-cCBT versus enhanced usual care (EUC) on: a) patient symptomatic, functional, and recovery-oriented outcomes, b) depression coping skills, antidepressant medication adherence, and initiation and completion of more intensive traditional psychotherapy (contingent on symptom level). Our secondary aims are to assess patient, peer, and providers' experiences in PS-cCBT versus EUC using mixed methods. Finally, our exploratory aim is to assess potential mediators of improvements in depressive symptoms or functional status. Methods: This is a Hybrid I randomized controlled trial (RCT) of peer-supported cCBT compared to enhanced usual care (EUC) among Veterans with new diagnoses of depression in primary care. The cCBT program consists of 8 modules and will be supported by VA peer specialists with weekly contact for 12 weeks. We will assess patient symptomatic, functional and recovery-oriented outcomes at 12 and 24 week following randomization. We will also assess potential mediators of these outcomes. Bivariate and multivariate study analyses will assess the impact of the two study arms at each assessment point and over time. Status: Study is currently ongoing, study recruitment and follow-up is active.

Interventions

BEHAVIORALPeer-assisted computerized CBT

Patients in the PS-cCBT intervention will receive usual depression care and will also receive: 1) access to Beating the Blues (BTB), an online cCBT program, 2) support of a peer specialists for 12 weeks, 3) a copy of the Depression Helpbook by Wayne Katon and colleagues

BEHAVIORALEnhanced usual care

Patients randomized to EUC will receive the following enhancements: 1) patient education regarding the symptoms of depression and evidence-based depression treatments, 2) a copy of the Depression Helpbook by Wayne Katon and colleagues 3) information about how to access local VA mental health depression treatment resources (groups, individual psychotherapy, etc), and 4) bi-weekly study mailings with depression management tips.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients will be eligible for the study if they: * have new episodes of depression in primary care, defined as those with a new diagnoses of depression and no prior depression diagnoses or antidepressant fills within 120 days of the index date of their depression diagnosis any of three VA study sites or associated CBOCs. Patients must enroll within 90 days of their diagnosis. * have a current Patient Health Questionnaire (PHQ)-9 score \> 10. * are not receiving mental health care outside of VHA. * have broadband internet access at home or confirm willingness, ability, and a plan to go to their VA facility to complete cCBT modules. * have familiarity with email and internet use. * have stable access to and ability to communicate by telephone.

Design outcomes

Primary

MeasureTime frameDescription
Depression Symptomschange over time (baseline, 3 months, 6 months)Inventory of Depressive Symptoms (IDS) at baseline, 3 months post intervention and 6 months post intervention. The ISD is a 16-item self-report instrument for measuring the severity of depression among individuals. Each item is rated on a four-point scale (0-3), and aggregate scores range from 0 to 27. The IDS has been widely used and shows acceptable reliability, with Cronbach's of 0.86. Severity of depression is scored according to the following ranges: 1-5 (no depression), 6-10 (mild), 11-15 (moderate), 16-20 (severe), and 21-27 (very severe).
Functional Statuschange over time (baseline, 3 months, 6 months)Functional status will be measured using the Veterans RAND 12-Item Health Survey (VR-12). Developed from VR-36, VR-12 includes 12 original question items from the VR-36. The questions in this survey correspond to seven different health domains inlcuding general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health. Answers are summarized into a Physical Component Score (PCS) and a Mental Component Score (MCS) which allows for a comparison between the respondents physical and psychological health status.The VR-12 has somewhat greater precision at the lower end of the health status continuum than the SF-12. The VR-12 has been used in numerous prior VA focused studies. VR-12 MCS component scores are standardized to a mean of 50, with higher scores indicating better mental health and related functioning.
Recovery Orientationchange over time (baseline, 3 months, 6 months)Recovery orientation will be measured using the Recovery Assessment Scale - Short Form (RAS-SF). This 20-item scale is a shorter version of the RAS and has four factors: personal confidence and hope, willingness to ask for help, reliance on others, and no domination by symptoms. The RAS-SF shows evidence for both convergent and discriminate validity when compared to quality of life, social support, and symptomatic scales. The scale is scored by summing all items (or scale items), with 100 being the highest possible overall score. Higher scores indicate greater sense of recovery.
Quality of Life Enjoyment and Satisfactionchange over time (baseline, 3 months, 6 months)The Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF) is a valid proxy for the longer Quality of Life Enjoyment and Satisfaction (Q-LES) form and will be used to assess quality of life. It consists of 14 items that patients rate on a 5-point scale to indicate their satisfaction with a variety of life domains, including physical health, mood, work, household activities, social relationships, etc. The Q-LES-Q-SF has been shown to have high levels of reliability and has been used in numerous studies of depression, including the National Institute of Mental Health (NIMH) funded STAR\*D study. Responses are scored on a 5-point scale, where higher scores indicate better enjoyment and satisfaction with life (possible range 14-70).

Secondary

MeasureTime frameDescription
Cognitive Behavioral Therapy Skillschange over time (baseline, 3 months, 6 months)CBT skills will be assessed using the Cognitive-Behavioral Therapy Skills Questionnaire (CBTSQ). The CBTSQ is a 16-item scale consisting of two factors, Behavioral Activation and Cognitive Restructuring. The scale shows construct validity, appears sensitive to change among patients undergoing CBT treatment, and predicts reduction in depressive symptoms. Scores are summed with a maximum score of 80. Higher scores indicate greater uptake of CBT skills.
Anxietychange over time (baseline, 3 months, 6 months)Generalized Anxiety will be measured with the Generalized Anxiety Disorder 7-item (GAD-7). Total score ranges from 0 to 21, with cut scores for mild, moderate and severe anxiety. Although originally developed for generalized anxiety disorder symptoms, the GAD-7 has good operating characteristics for detection and severity ratings of panic disorder and social anxiety disorder. Scores are summed with a range of 0-21. Scores represent: 0-5 mild, 6-10 moderate, 11-15 moderate/severe, and 15-21 severe anxiety.

Countries

United States

Participant flow

Participants by arm

ArmCount
Enhanced Usual Care
Enhanced usual care: Patients randomized to EUC will receive the following enhancements: 1) patient education regarding the symptoms of depression and evidence-based depression treatments, 2) a copy of the Depression Helpbook by Wayne Katon and colleagues 3) information about how to access local VA mental health depression treatment resources (groups, individual psychotherapy, etc), and 4) bi-weekly study mailings with depression management tips.
163
PS-cCBT
Peer-assisted computerized CBT: Patients in the PS-cCBT intervention will receive usual depression care and will also receive: 1) access to Beating the Blues (BTB), an online cCBT program, 2) support of a peer specialists for 12 weeks, 3) a copy of the Depression Helpbook by Wayne Katon and colleagues
167
Total330

Baseline characteristics

CharacteristicEnhanced Usual CarePS-cCBTTotal
Age, Continuous51.7 years
STANDARD_DEVIATION 15.5
51.6 years
STANDARD_DEVIATION 14.4
51.6 years
STANDARD_DEVIATION 14.9
Education
College graduate
61 Participants63 Participants124 Participants
Education
High school or less
37 Participants21 Participants58 Participants
Education
Some college
64 Participants82 Participants146 Participants
Race/Ethnicity, Customized
Black
31 Participants37 Participants68 Participants
Race/Ethnicity, Customized
Hispanic
3 Participants6 Participants9 Participants
Race/Ethnicity, Customized
Other
13 Participants15 Participants28 Participants
Race/Ethnicity, Customized
White
119 Participants115 Participants234 Participants
Sex: Female, Male
Female
29 Participants36 Participants65 Participants
Sex: Female, Male
Male
134 Participants131 Participants265 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1630 / 167
other
Total, other adverse events
0 / 1630 / 167
serious
Total, serious adverse events
0 / 1630 / 167

Outcome results

Primary

Depression Symptoms

Inventory of Depressive Symptoms (IDS) at baseline, 3 months post intervention and 6 months post intervention. The ISD is a 16-item self-report instrument for measuring the severity of depression among individuals. Each item is rated on a four-point scale (0-3), and aggregate scores range from 0 to 27. The IDS has been widely used and shows acceptable reliability, with Cronbach's of 0.86. Severity of depression is scored according to the following ranges: 1-5 (no depression), 6-10 (mild), 11-15 (moderate), 16-20 (severe), and 21-27 (very severe).

Time frame: change over time (baseline, 3 months, 6 months)

Population: Numbers analyzed in each time period account for attrition in follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Enhanced Usual CareDepression SymptomsBaseline13.4 score on a scaleStandard Deviation 3.6
Enhanced Usual CareDepression Symptoms3 months11.7 score on a scaleStandard Deviation 4.1
Enhanced Usual CareDepression Symptoms6 months11.2 score on a scaleStandard Deviation 4.4
PS-cCBTDepression SymptomsBaseline14.0 score on a scaleStandard Deviation 3.9
PS-cCBTDepression Symptoms3 months11.1 score on a scaleStandard Deviation 4.7
PS-cCBTDepression Symptoms6 months10.6 score on a scaleStandard Deviation 5.1
p-value: <0.05Mixed Models Analysis
Primary

Functional Status

Functional status will be measured using the Veterans RAND 12-Item Health Survey (VR-12). Developed from VR-36, VR-12 includes 12 original question items from the VR-36. The questions in this survey correspond to seven different health domains inlcuding general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health. Answers are summarized into a Physical Component Score (PCS) and a Mental Component Score (MCS) which allows for a comparison between the respondents physical and psychological health status.The VR-12 has somewhat greater precision at the lower end of the health status continuum than the SF-12. The VR-12 has been used in numerous prior VA focused studies. VR-12 MCS component scores are standardized to a mean of 50, with higher scores indicating better mental health and related functioning.

Time frame: change over time (baseline, 3 months, 6 months)

Population: Numbers analyzed in each time period account for attrition in follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Enhanced Usual CareFunctional StatusBaseline32.1 score on a scaleStandard Deviation 9.9
Enhanced Usual CareFunctional Status3 months36.2 score on a scaleStandard Deviation 10.3
Enhanced Usual CareFunctional Status6 months37.1 score on a scaleStandard Deviation 11
PS-cCBTFunctional StatusBaseline31.4 score on a scaleStandard Deviation 9.7
PS-cCBTFunctional Status3 months37.3 score on a scaleStandard Deviation 11.5
PS-cCBTFunctional Status6 months40.1 score on a scaleStandard Deviation 12.2
p-value: <0.05Mixed Models Analysis
Primary

Quality of Life Enjoyment and Satisfaction

The Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF) is a valid proxy for the longer Quality of Life Enjoyment and Satisfaction (Q-LES) form and will be used to assess quality of life. It consists of 14 items that patients rate on a 5-point scale to indicate their satisfaction with a variety of life domains, including physical health, mood, work, household activities, social relationships, etc. The Q-LES-Q-SF has been shown to have high levels of reliability and has been used in numerous studies of depression, including the National Institute of Mental Health (NIMH) funded STAR\*D study. Responses are scored on a 5-point scale, where higher scores indicate better enjoyment and satisfaction with life (possible range 14-70).

Time frame: change over time (baseline, 3 months, 6 months)

Population: Numbers analyzed in each time period account for attrition in follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Enhanced Usual CareQuality of Life Enjoyment and SatisfactionBaseline38.8 score on a scaleStandard Deviation 8.7
Enhanced Usual CareQuality of Life Enjoyment and Satisfaction3 months40.5 score on a scaleStandard Deviation 9.9
Enhanced Usual CareQuality of Life Enjoyment and Satisfaction6 months41.0 score on a scaleStandard Deviation 10.4
PS-cCBTQuality of Life Enjoyment and SatisfactionBaseline37.7 score on a scaleStandard Deviation 8.3
PS-cCBTQuality of Life Enjoyment and Satisfaction3 months41.6 score on a scaleStandard Deviation 9.9
PS-cCBTQuality of Life Enjoyment and Satisfaction6 months42.5 score on a scaleStandard Deviation 10.7
p-value: <0.05Mixed Models Analysis
Primary

Recovery Orientation

Recovery orientation will be measured using the Recovery Assessment Scale - Short Form (RAS-SF). This 20-item scale is a shorter version of the RAS and has four factors: personal confidence and hope, willingness to ask for help, reliance on others, and no domination by symptoms. The RAS-SF shows evidence for both convergent and discriminate validity when compared to quality of life, social support, and symptomatic scales. The scale is scored by summing all items (or scale items), with 100 being the highest possible overall score. Higher scores indicate greater sense of recovery.

Time frame: change over time (baseline, 3 months, 6 months)

Population: Numbers analyzed in each time period account for attrition in follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Enhanced Usual CareRecovery Orientation3 months71.7 score on a scaleStandard Deviation 10.5
Enhanced Usual CareRecovery OrientationBaseline69.3 score on a scaleStandard Deviation 9.7
Enhanced Usual CareRecovery Orientation6 months71.1 score on a scaleStandard Deviation 11.7
PS-cCBTRecovery OrientationBaseline67.1 score on a scaleStandard Deviation 11.1
PS-cCBTRecovery Orientation3 months72.6 score on a scaleStandard Deviation 13.7
PS-cCBTRecovery Orientation6 months74.1 score on a scaleStandard Deviation 14.6
p-value: <0.05Mixed Models Analysis
Secondary

Anxiety

Generalized Anxiety will be measured with the Generalized Anxiety Disorder 7-item (GAD-7). Total score ranges from 0 to 21, with cut scores for mild, moderate and severe anxiety. Although originally developed for generalized anxiety disorder symptoms, the GAD-7 has good operating characteristics for detection and severity ratings of panic disorder and social anxiety disorder. Scores are summed with a range of 0-21. Scores represent: 0-5 mild, 6-10 moderate, 11-15 moderate/severe, and 15-21 severe anxiety.

Time frame: change over time (baseline, 3 months, 6 months)

Population: Numbers analyzed in each time period account for attrition in follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Enhanced Usual CareAnxietyBaseline11.3 score on a scaleStandard Deviation 4.7
Enhanced Usual CareAnxiety3 months9.5 score on a scaleStandard Deviation 4.8
Enhanced Usual CareAnxiety6 months9.3 score on a scaleStandard Deviation 5.1
PS-cCBTAnxiety6 months8.1 score on a scaleStandard Deviation 5.2
PS-cCBTAnxietyBaseline11.0 score on a scaleStandard Deviation 4.3
PS-cCBTAnxiety3 months8.8 score on a scaleStandard Deviation 5.1
p-value: <0.05t-test, 2 sided
Secondary

Cognitive Behavioral Therapy Skills

CBT skills will be assessed using the Cognitive-Behavioral Therapy Skills Questionnaire (CBTSQ). The CBTSQ is a 16-item scale consisting of two factors, Behavioral Activation and Cognitive Restructuring. The scale shows construct validity, appears sensitive to change among patients undergoing CBT treatment, and predicts reduction in depressive symptoms. Scores are summed with a maximum score of 80. Higher scores indicate greater uptake of CBT skills.

Time frame: change over time (baseline, 3 months, 6 months)

Population: Numbers analyzed in each time period account for attrition in follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Enhanced Usual CareCognitive Behavioral Therapy SkillsBaseline42.4 score on a scaleStandard Deviation 10.2
Enhanced Usual CareCognitive Behavioral Therapy Skills3 months45.1 score on a scaleStandard Deviation 10.7
Enhanced Usual CareCognitive Behavioral Therapy Skills6 months45.9 score on a scaleStandard Deviation 10.8
PS-cCBTCognitive Behavioral Therapy SkillsBaseline40.4 score on a scaleStandard Deviation 11
PS-cCBTCognitive Behavioral Therapy Skills3 months46.1 score on a scaleStandard Deviation 12.6
PS-cCBTCognitive Behavioral Therapy Skills6 months48.0 score on a scaleStandard Deviation 14.3
p-value: <0.05t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026